Delivery Order SPE2DB20D1100-SPE2DB25FD8R5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,677.02 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $11,924.99 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract was competitively awarded without set-aside designation and carries a firm fixed-price structure with an ultimate completion date of August 5, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is...
- The Defense Logistics Agency awarded a $2,381.85 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract was issued under a non-set-aside procurement and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $11,472.94 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform the delivery from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency awarded a $1,631.10 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication, with delivery required by September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's larger pharmaceutical supply framework supporting federal healthcare needs. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,428.97 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. The order was competitively awarded on July 14, 2025, under a firm fixed price contract type with an ultimate completion date of July 15, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,482.71 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. This firm fixed price delivery order, awarded on September 12, 2025, with a completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a routine pharmaceutical supply delivery under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8R5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,624.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's federal procurement portfolio demonstrates consistent capability in fulfilling defense medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/5/25 |